
    
      The objectives of this surveillance are to identify problems/questions regarding the
      followings in the clinical practice of using NexavarÂ®.

        1. Unknown adverse events (in particular, serious adverse events)

        2. Identification of adverse events occurred in the real practice.

        3. Factors that are considered to affect on safety.

        4. Factors that are considered to affect on effectiveness
    
  